Table 3 Metastasis prediction: top score pathways sampled by the different algorithms
From: Robust pathway sampling in phenotype prediction. Application to triple negative breast cancer
FRS | HS | ||
|---|---|---|---|
Score | Top Pathways | Score | Top Pathways |
10.3 | Direct P53 Effectors | 11.2 | JNK Signaling in CD4+ TCR Pathway |
10.1 | DREAM Repression & Dynorphin Exp. | 9.7 | RhoA Signaling Pathway |
9.6 | P53 Signaling | 8.3 | ATM Pathway |
8.8 | RhoA Signaling Pathway | 8.1 | FoxO Signaling Pathway |
8.4 | P53 Pathway | 8.0 | TGF-beta Signaling Pathway |
RS | BN | ||
Score | Top Pathways | Score | Top Pathways |
15.0 | DREAM Repression & Dynorphin Exp. | 8.1 | Direct P53 Effectors |
10.1 | Direct P53 Effectors | 8.0 | Proteolysis Putative SUMO-1 Pathway |
10.1 | Immune Response Role of DAP12 Receptors in NK Cells | 7.1 | Creation of C4 and C2 Activators |
9.9 | JNK Signaling in CD4+ TCR Pathway | 6.9 | TGF-beta Receptor Signaling |
9.8 | MAPK Signaling Pathway | 6.8 | MTOR Signaling Pathway |